Delivery Order SPE2DB20D1109-SPE2DB24FP65Z

Award Date 8/7/24
Potential Completion Date 8/8/24
Potential Value $3.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,593.95 delivery order contract is for the supply of DUROLANE 60 MG/3 ML SYRINGE 3ML, a medical product, with a completion date of February 28, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,068.33 firm fixed-price delivery order is for the supply of 4,568,037,376 units of the 60 mg/3 mL DUROLANE syringe. The contract has an ultimate completion date of April 28, 2025 and is not set aside. AmerisourceBergen Drug Corp holds a substantial $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,395.62 firm fixed-price delivery order is for the supply of DUROLANE 60 MG/3 ML SYRINGE 3ML medical products, with a completion date of November 4, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $22,251.73 firm fixed price Delivery Order contract provides DUROLANE 60 MG/3 ML SYRINGE 3ML, a medical supply product, with a period of performance running through January 2025. The award is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,957.70, is for the delivery of DUROLANE 60 MG/3 ML SYRINGE 3ML medical supplies. This is a firm fixed-price delivery order contract with a completion date of February 28, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,089.87 Firm Fixed Price Delivery Order contract is for the supply of DUROLANE 60 MG/3 ML SYRINGE 3ML, a medical product, with a period of performance through June 13, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,248.11, is a delivery order for the supply of DUROLANE 60 MG/3 ML SYRINGE 3ML, a medical product. The contract has a firm fixed price pricing type and a performance period extending to May 7, 2025. This award is not designated as a set-aside contract. AmerisourceBergen Drug Corp holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,375.80 firm-fixed-price delivery order is for the supply of DUROLANE 60 MG/3 ML SYRINGE 3ML, a pharmaceutical product. The contract has an ultimate completion date of May 6, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The $5,330.58 firm fixed price delivery order is for the supply of 4564297433 DUROLANE 60 MG/3 ML SYRINGE 3ML. The contract has an ultimate completion date of April 17, 2024. AmerisourceBergen holds a single-award Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,257.17 firm fixed price delivery order is for the supply of 4567522902 DUROLANE 60 MG/3 ML SYRINGE 3ML, with a performance period through March 11, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
  • SPE2DB20D1109
    Indefinite Delivery Contract
  • SPE2DB20D1109-SPE2DB24FP65Z
    Delivery Order

This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,799.33 firm fixed-price delivery order is for the supply of DUROLANE 60 MG/3 ML SYRINGE 3ML, a medical product. The award has an ultimate completion date of August 8, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation through May 2024, covering similar medical products and prescription drugs. This contract award was not designated with any set-aside requirements.

Generated 2/27/25, 1:11 PM